ArticleFrontiers in endocrinology2025
Distinct patterns of association between the hemoglobin glycation index, the stress-hyperglycemia ratio, and the risk of new-onset atrial fibrillation in critically ill patients.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigated the associations between two novel glycemic indices, the hemoglobin glycation index (HGI) and the stress hyperglycemia ratio (SHR), and the risk of new-onset atrial fibrillation (NOAF) in critically ill patients. Methods: We retrospectively analyzed data from 3,882 adults in the MIMIC-IV database, with the primary outcome defined as NOAF within 7 days of intensive care unit (ICU) admission. Multivariate Cox regression and restricted cubic spline analyses were used to evaluate associations. Results: NOAF occurred in 750 patients (19.3%). After adjustment for confounders, HGI exhibited a significant inverted U-shaped association with NOAF risk, with the highest risk in intermediate quartiles. In contrast, the SHR demonstrated a significant linear inverse relationship with NOAF risk, with higher SHR quartiles consistently associated with lower risk. These associations were especially pronounced in nondiabetic patients and remained consistent across key clinical subgroups. Conclusion: Our findings indicate that the HGI and SHR independently predict NOAF in critically ill patients and may provide valuable tools for risk stratification and personalized glycemic management in the ICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.